Insights
Recon takes an analytical look behind select developments in healthcare
Keep up with Recon Strategy Insights
Get an email each time we publish a new article
Search
- By Lilian Zhang, Tory Wolff, and Jason Brauner
Introduction
Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisio…
- By Megna Srinivasan, Jason Brauner, and Tory Wolff
Survivorship care is increasingly pivotal to cancer care delivery and system capacity
By 2040, 26.1 million Americans will be cancer survivors, representing ~7% of the nation.[1] This is prompting na…
- By Marc Herant
Looking for zebras
“When you hear hoofbeats, think of horses, not zebras” is a classic dictum of medical practice, useful because it avoids many futile diagnostic expeditions. However, it does mean th…
- By Jason Brauner, Phil Berk, and Lilian Zhang
Introduction
As we described in a prior whitepaper, explaining over- and under-performance of newly launched therapies relative to pre-launch expectations is a critical element to enabling robust prod…
- By Lilian Zhang, Jason Brauner, and Marc Herant
In our previous analyses (2023[1] and 2024[2]), we tracked two oncology development cohorts using a Kaplan–Meier framework to visualize how quickly programs reach a terminal outcome—either an FDA appr…
- By Chisom Chukwu
About the author: Chisom is currently a high school senior attending Boston Latin School. She spent the summer of 2025 with Recon Strategy as a paid intern assigned a project to research the effect of…
- By Marc Herant
Exercise with cancer: it’s about more than fitness
Retrospective observational studies very frequently highlight the correlation of various lifestyle characteristics with outcomes, but most of the tim…
- By Jacob Wiesenthal and Tory Wolff
More frequent routine primary care visits for certain higher-risk commercially insured adults are associated with lower net population-level health care costs.…
- By Jacob Wiesenthal and Tory Wolff
A new AJMC study from consulting firm Recon Strategy is the first to show how advanced primary care techniques, previously proven in older Medicare populations, could also deliver substantial savings …